Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (325) Arrow Down
Filter Results: (325) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (1,454)
    • Faculty Publications  (325)

    Show Results For

    • All HBS Web  (1,454)
      • Faculty Publications  (325)

      healthcareRemove healthcare →

      ← Page 12 of 325 Results →

      Are you looking for?

      →Search All HBS Web
      • November–December 2014
      • Article

      Using Time-Driven Activity-Based Costing to Identify Value-Improvement Opportunities in Healthcare

      By: Robert S. Kaplan, Mary L. Witkowski, Megan Abbott, Alexis Guzman, Laurence Higgins, John Meara, Erin Padden, Apurva Shah, Peter Waters, Marco Weidemeier, Samuel Wertheimer and Thomas W. Feeley
      As healthcare providers cope with pricing pressures and increased accountability for performance, they should be rededicating themselves to improving the value they deliver to their patients: better outcomes and lower costs. Time-driven activity-based costing offers... View Details
      Keywords: Value Creation; Activity Based Costing and Management; Health Care and Treatment; Health Industry; United States; Europe
      Citation
      Find at Harvard
      Related
      Kaplan, Robert S., Mary L. Witkowski, Megan Abbott, Alexis Guzman, Laurence Higgins, John Meara, Erin Padden, Apurva Shah, Peter Waters, Marco Weidemeier, Samuel Wertheimer, and Thomas W. Feeley. "Using Time-Driven Activity-Based Costing to Identify Value-Improvement Opportunities in Healthcare." Journal of Healthcare Management 59, no. 6 (November–December 2014): 399–413.
      • October 2014 (Revised April 2023)
      • Case

      Gilead: Hepatitis C Access Strategy (A)

      By: V. Kasturi Rangan, Vikram Rangan and David E. Bloom
      Gilead had come up with an innovative drug for Hepatitis C, which affected 180 million people worldwide. The drug was priced at $1,000 a pill for the US market. Gilead had to decide how to price and market the pill in developing countries that bore the brunt of the... View Details
      Keywords: Healthcare; Pharmaceuticals; Pricing; Access To Care; Emerging Markets; Health Care and Treatment; Price; Strategy; Ethics; Health Industry; Pharmaceutical Industry
      Citation
      Educators
      Purchase
      Related
      Rangan, V. Kasturi, Vikram Rangan, and David E. Bloom. "Gilead: Hepatitis C Access Strategy (A)." Harvard Business School Case 515-025, October 2014. (Revised April 2023.)
      • September 2014 (Revised May 2017)
      • Case

      Fresno's Social Impact Bond for Asthma

      By: John A. Quelch and Margaret L. Rodriguez
      In 2014, Social Impact Bonds (SIBs) were quickly gaining popularity as an investment vehicle which joined together private investors and nonprofits to tackle social issues. Although numerous SIB projects and proposals had cropped up across the U.S. following the launch... View Details
      Keywords: Social Enterprise; Health Care; Marketing; Bonds; Financing; Asthma; Air Pollution; Air Quality; Chronic Disease; Public Health; Health; Health Care and Treatment; Finance; Health Industry; Financial Services Industry; United States
      Citation
      Educators
      Purchase
      Related
      Quelch, John A., and Margaret L. Rodriguez. "Fresno's Social Impact Bond for Asthma." Harvard Business School Case 515-028, September 2014. (Revised May 2017.)
      • September 2014
      • Case

      FormPrint Ortho500

      By: Frank V. Cespedes and Alisa Zalosh
      The Senior Vice President of FormPrint's Medical Products business unit is considering issues raised by the upcoming introduction of a new 3D printing system, the Ortho500, which could print custom exoskeletal orthopedic splints, braces, and casts that conformed to a... View Details
      Keywords: B2B Marketing; Technological Innovation; Market Entry and Exit; Marketing Strategy; Distribution Channels; Product Development; Medical Devices and Supplies Industry
      Citation
      Educators
      Purchase
      Related
      Cespedes, Frank V., and Alisa Zalosh. "FormPrint Ortho500." Harvard Business School Brief Case 915-535, September 2014.
      • July 2014 (Revised January 2017)
      • Course Overview Note

      Building Life Science Businesses Spring Term 2017: Course Outline and Syllabus

      By: Richard G. Hamermesh
      This Course Outline and Syllabus gives an overview of the Spring 2016 class Building Life Science Businesses.7 View Details
      Keywords: Healthcare Ventures; Entrepreneurial Management; Entrepreneurship; Entrepreneurs; Health Care and Treatment; Health Testing and Trials; Medical Specialties; Health Industry; Biotechnology Industry; Medical Devices and Supplies Industry; Asia; North America; Europe
      Citation
      Purchase
      Related
      Hamermesh, Richard G. "Building Life Science Businesses Spring Term 2017: Course Outline and Syllabus." Harvard Business School Course Overview Note 815-003, July 2014. (Revised January 2017.)
      • September 2014
      • Article

      Structural Models of Complementary Choices

      By: Steven T. Berry, Ahmed Khwaja, Vineet Kumar, Andres Musalem, Kenneth C. Wilbur, Greg Allenby, Bharat Anand, Pradeep K. Chintagunta, W. Michael Hanemann, Przemyslaw Jeziorski and Angelo Mele
      Complementary choices are important and pervasive yet occasionally elusive. Single consumers make complementary choices in purchase decisions (e.g., chips and salsa), product inter-operabilities (smartphones and networks), and dynamic decisions (current exercise and... View Details
      Keywords: Decision Choices and Conditions; Consumer Behavior
      Citation
      Find at Harvard
      Read Now
      Related
      Berry, Steven T., Ahmed Khwaja, Vineet Kumar, Andres Musalem, Kenneth C. Wilbur, Greg Allenby, Bharat Anand, Pradeep K. Chintagunta, W. Michael Hanemann, Przemyslaw Jeziorski, and Angelo Mele. "Structural Models of Complementary Choices." Marketing Letters 25, no. 3 (September 2014): 245–256.
      • June 2014 (Revised September 2014)
      • Case

      Johnson & Johnson: The Promotion of Wellness

      By: John A. Quelch and Carin-Isabel Knoop
      To create the world's healthiest workforce, diversified health care giant Johnson & Johnson (J&J) mandated participation in its "Culture of Health" program globally, customized by location, culture, and specific health needs to offer prevention-focused education,... View Details
      Keywords: Healthcare; Employee Motivation; Transformation; Ethics; Health; Human Resources; Leadership; Management; Personal Development and Career; Problems and Challenges; Strategy; Health Industry; Medical Devices and Supplies Industry; Pharmaceutical Industry; North and Central America; Middle East; Latin America; Europe; Asia
      Citation
      Educators
      Purchase
      Related
      Quelch, John A., and Carin-Isabel Knoop. "Johnson & Johnson: The Promotion of Wellness." Harvard Business School Case 514-112, June 2014. (Revised September 2014.)
      • June 2014 (Revised May 2017)
      • Teaching Note

      Vision 2020: Takeda and the Vaccine Business

      By: John A. Quelch
      Keywords: Asia; Healthcare; Pharmaceuticals; Innovation And Management; Health; Innovation and Invention; Strategy; Leadership; Growth and Development; Change; Health Industry; Pharmaceutical Industry; Asia
      Citation
      Purchase
      Related
      Quelch, John A. "Vision 2020: Takeda and the Vaccine Business." Harvard Business School Teaching Note 514-105, June 2014. (Revised May 2017.)
      • June 2014
      • Article

      Improving Value with TDABC

      By: Robert S. Kaplan
      The article discusses the benefits of time-driven activity-based costing (TDABC) combined with outcomes measurement for healthcare organizations. Topics covered include improving resource efficiency, optimizing care over the complete care cycle, and planning and... View Details
      Keywords: Goals and Objectives; Activity Based Costing and Management; Health Care and Treatment; Health Industry
      Citation
      Find at Harvard
      Related
      Kaplan, Robert S. "Improving Value with TDABC." hfm (Healthcare Financial Management) 68, no. 6 (June 2014): 76–83.
      • May 2014 (Revised March 2016)
      • Case

      Health City Cayman Islands

      By: Tarun Khanna and Budhaditya Gupta
      Narayana Health (NH) had been successfully delivering affordable high quality tertiary care to the masses in India through its chain of hospitals for over a decade. To encourage the adoption of the NH affordable care delivery model worldwide, Dr. Shetty, Chairman of... View Details
      Keywords: Healthcare; Emerging Economies; Innovation; India; Institutions; Pricing; Replication; Strategy; Narayana Health; Ascension; Health City Cayman Islands; Dr. Devi Shetty; International Business; Health Care and Treatment; Innovation Strategy; Innovation and Management; Disruptive Innovation; Cross-Cultural and Cross-Border Issues; Global Strategy; Knowledge Use and Leverage; Management Practices and Processes; Growth Management; Growth and Development Strategy; Market Entry and Exit; Adaptation; Adoption; India; Cayman Islands
      Citation
      Educators
      Purchase
      Related
      Khanna, Tarun, and Budhaditya Gupta. "Health City Cayman Islands." Harvard Business School Case 714-510, May 2014. (Revised March 2016.)
      • April 2014 (Revised January 2015)
      • Background Note

      Note on Mobile Healthcare

      By: John A. Quelch and Margaret L. Rodriguez
      Delivering health care to the global population was a challenge. Health care costs accounted for ten percent of world GDP by 2013. In the U.S., health care costs were expected to top $3.1 trillion in 2014. New technologies, shortages of trained personnel and... View Details
      Keywords: Health Care; Mobile; Mobile App; Public Health; Startups; Hardware; Software; Telemedicine; Global; Medical Devices; Medical Services; Medical Solutions; Entrepreneurs; Government And Business; Technological Change; Health Care and Treatment; Entrepreneurship; Government and Politics; Technological Innovation; Applications and Software; Information Infrastructure; Health Industry; Technology Industry
      Citation
      Educators
      Purchase
      Related
      Quelch, John A., and Margaret L. Rodriguez. "Note on Mobile Healthcare." Harvard Business School Background Note 514-122, April 2014. (Revised January 2015.)
      • March 2014 (Revised September 2017)
      • Case

      salaUno: Eliminating Needless Blindness in Mexico

      By: Richard Hamermesh, Regina Garcia Cueller and Valeria Moy
      In May 2013 the co-founders and co-CEOs of salaUno, Javier Okhuysen and Carlos Orellana, were encouraged by the results of their fledgling start-up. salaUno was founded as a for-profit enterprise in order to have the capital needed for rapid growth and to fulfill its... View Details
      Keywords: Medical Services; Developing Countries; Developing Markets; Health Care Industry; Health Services; Healthcare Ventures; Healthcare Startups; Health Care and Treatment; Health; Business Startups; Developing Countries and Economies; Growth and Development Strategy; Health Industry; Mexico; Mexico City
      Citation
      Educators
      Purchase
      Related
      Hamermesh, Richard, Regina Garcia Cueller, and Valeria Moy. "salaUno: Eliminating Needless Blindness in Mexico." Harvard Business School Case 814-041, March 2014. (Revised September 2017.)
      • March 2014 (Revised September 2014)
      • Supplement

      Cancer Treatment Centers of America® (B)

      By: Regina E. Herzlinger and Natalie Kindred
      This case, a follow-up to Cancer Treatment Centers of America (A), HBS No. 313-012, begins with the debate over New Hampshire's certificate-of-need (CON) law, which restricts hospital expansion. This debate ignited significant public criticism of Cancer Treatment... View Details
      Keywords: Cancer; Cancer Treatment; Accountability; Outcomes; Outcomes Reporting; Outcomes Measurement; Survival; For-profit Hospitals; Health Care; Healthcare; Hospital; Certificate Of Need; Health Care and Treatment; Outcome or Result; Corporate Accountability; Policy; Health Industry; United States
      Citation
      Purchase
      Related
      Herzlinger, Regina E., and Natalie Kindred. "Cancer Treatment Centers of America® (B)." Harvard Business School Supplement 314-003, March 2014. (Revised September 2014.)
      • March 2014
      • Teaching Note

      E-Cigarettes: Marketing Versus Public Health

      By: John A. Quelch
      Electronic cigarettes (e-cigarettes) were heralded by some as a healthcare game changer, enabling smokers to switch to a new product which carried lower risk of cancer. However, there were concerns about the public health risk of e-cigarettes, particularly the chance... View Details
      Citation
      Purchase
      Related
      Quelch, John A. "E-Cigarettes: Marketing Versus Public Health." Harvard Business School Teaching Note 514-108, March 2014.
      • January 2014
      • Teaching Note

      Dr. Benjamin Hooks and Children's Health Forum

      By: Rosabeth Moss Kanter and Ai-Ling Malone
      The case includes law, business, and public health perspectives on an African American leader's social entrepreneurship and leadership in other social movements. Later in his life, Dr. Benjamin Hooks championed the eradication of lead poisoning. Prior to that Hooks... View Details
      Keywords: Leading Change; Health Disorders; Social Entrepreneurship; Personal Development and Career; Social Issues; United States
      Citation
      Purchase
      Related
      Kanter, Rosabeth Moss, and Ai-Ling Malone. "Dr. Benjamin Hooks and Children's Health Forum." Harvard Business School Teaching Note 314-092, January 2014.
      • January 2014 (Revised January 2014)
      • Supplement

      GlaxoSmithKline in China (C)

      By: John Quelch and Margaret L. Rodriguez
      Keywords: China; Healthcare; Pharmaceutical Sales; Ethics; Multinational Firms and Management; Pharmaceutical Industry; China
      Citation
      Purchase
      Related
      Quelch, John, and Margaret L. Rodriguez. "GlaxoSmithKline in China (C)." Harvard Business School Supplement 514-092, January 2014. (Revised January 2014.) (This case is a follow up to GlaxoSmithKline (A), 514049 and GlaxoSmithKline (B), 514050.)
      • January 2014 (Revised January 2014)
      • Case

      Henry Schein: Doing Well by Doing Good?

      By: Rebecca Henderson, Raffaella Sadun, Aldo Sesia and Russell Eisenstat

      Henry Schein Inc., a distributor of supplies to dentist, physician, and veterinary practices, had sales approaching $9 billion and employed nearly 16,000 people. The company had experienced impressive growth under the leadership of Stanley Bergman and his executive... View Details

      Keywords: Leadership Development; Strategy Execution; Performance Management; Corporate Culture; Social Responsibility; Mergers & Acquisitions; Joint Ventures; Partnerships; Health Care Industry; Healthcare Logistics Industry; Competitive Advantage; Strategy; Leadership; Global Strategy; Selection and Staffing; Management Style; Organizational Culture; Corporate Social Responsibility and Impact; Health Industry; Medical Devices and Supplies Industry; China; Europe; United States
      Citation
      Educators
      Purchase
      Related
      Henderson, Rebecca, Raffaella Sadun, Aldo Sesia, and Russell Eisenstat. "Henry Schein: Doing Well by Doing Good?" Harvard Business School Case 714-450, January 2014. (Revised January 2014.)
      • January 2014
      • Teaching Plan

      MedImmune Ventures

      By: Richard Hamermesh and Andrew Otazo
      "MedImmune Ventures" highlights the problems faced by corporate venture capital firms, the challenges of investing in early-stage healthcare, and the difficulty of operating in distant markets. View Details
      Keywords: MedImmune Ventures; NeuProtect; Corporate Venture Capital; Ron Laufer; Australia; Starfish Ventures; AstraZeneca; MEVE; Healthcare; Startup; Venture Capital; Business Startups; Health Industry; Australia; United States
      Citation
      Purchase
      Related
      Hamermesh, Richard, and Andrew Otazo. "MedImmune Ventures." Harvard Business School Teaching Plan 814-039, January 2014.
      • January–February 2014
      • Other Article

      Barriers to Health Care Innovation: Regina Herzlinger Warns That Innovators Need to Know What Obstacles They Face and How to Overcome Them

      By: Regina E. Herzlinger
      Health care in the United States and in most other developed countries is ailing, says Regina E. Herzlinger. A chaired professor of business administration specializing in health care at Harvard Business School, Herzlinger says that although the world has witnessed... View Details
      Keywords: Healthcare; Healthcare IT; Innovation; Health Care and Treatment; Health; Information Technology; Innovation and Invention; Health Industry; Technology Industry; United States
      Citation
      Find at Harvard
      Related
      Herzlinger, Regina E. "Barriers to Health Care Innovation: Regina Herzlinger Warns That Innovators Need to Know What Obstacles They Face and How to Overcome Them." IEEE Pulse 5, no. 1 (January–February 2014): 43–45.
      • 25 Nov 2013
      • Other Presentation

      Future of Healthcare Delivery

      By: Michael E. Porter
      Keywords: Health
      Citation
      Read Now
      Related
      Porter, Michael E. "Future of Healthcare Delivery." Medtronic, Minneapolis, MN, November 25, 2013.
      • ←
      • 12
      • 13
      • …
      • 16
      • 17
      • →

      Are you looking for?

      →Search All HBS Web
      ǁ
      Campus Map
      Harvard Business School
      Soldiers Field
      Boston, MA 02163
      →Map & Directions
      →More Contact Information
      • Make a Gift
      • Site Map
      • Jobs
      • Harvard University
      • Trademarks
      • Policies
      • Accessibility
      • Digital Accessibility
      Copyright © President & Fellows of Harvard College.